Therapeutic opportunity of phosphodiesterase 3A modulators in myxoid liposarcomas
Kirsi Toivanen(University of Helsinki), Harri Sihto(University of Helsinki)
Cited by 0
Related Papers
Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study
|Breast Cancer Research|2011|228
SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumour
|British Journal of Cancer|2017|17
Transcriptomic analyses reveal three distinct molecular subgroups of Merkel cell carcinoma with differing prognoses
|International Journal of Cancer|2023|12